JERUSALEM, Nov 15 (Reuters) – Israeli digital health firm AEYE Health said on Tuesday it received clearance from the U.S. Food and Drug Administration (FDA) to market its screening system to detect damage to the retina of the eyes in diabetics. Read more...
Read MoreDandelion Energy, which sells and installs geothermal heat pumps, has raised $70 million in a new funding round. Read...
Read MoreThis will allow nurses and case managers to better monitor patients and intervene faster Read...
Read MoreAn upward-thinking Israeli startup aims to put a flying car in every garage Read...
Read MoreAEYE Health and UMass Medical School, in collaboration with UMass Memorial Health Care, are developing a system which enables family doctors to screen patients for various retinal conditions and enable timely referrals to specialists. Read more...
Read More
